Good morning and welcome to Markets Desk, your end-of-week wrap on the commodity and policy moves that matter.
Wheat was the clear standout in the grain complex on Friday, with Kansas City hard red winter futures surging as much as thirty-three cents on the session and Chicago soft red winter contracts adding up to twenty-two cents. The weekly gain in Chicago alone reached thirty-five cents, with traders bidding up risk premium ahead of the weekend on renewed Black Sea supply concerns.
Turning to livestock, cattle futures came under meaningful pressure Friday, with contracts finishing eighty-five cents to two dollars and sixty cents lower on the day. August live cattle shed more than eight dollars on the week, a significant drawdown, and cash trade in the North settled in the two hundred twenty-five to two hundred twenty-eight dollar range, offering little support to the futures complex.
Meanwhile, a different kind of market is drawing investor attention in healthcare. Amgen is positioning itself as a credible alternative in the GLP-one obesity drug space, which has been dominated by Eli Lilly and Novo Nordisk. With demand for these weight-loss therapies soaring, analysts are watching second-tier developers closely for the next leg of growth in what remains one of the most dynamic sectors in equities.
That's the tape. Markets Desk, signing off the floor.
